News roundup Friday, April 25

Do you follow our Newsletter? Sign up here!

The latest news

Xintela and EQGen Biomedical signs collaboration and licensing agreements for stem cell products in veterinary medicine. Read more.

is implementing organizational changes to increase focus on the commercialization of the company's fully developed inhalation platforms. Read moreThe company also decides on a rights issue of shares of approximately SEK 36,6 million, subject to approval from an extraordinary general meeting. Read moreIconovo's nomination committee proposes the election of two new board members. Read more.

Arctic Bioscience presents results from the phase II study HeROPA in psoriasis. Read more.

Alzinova announces that the drug substance is now available for the upcoming Phase II clinical study of the vaccine candidate ALZ-101 for early Alzheimer's disease. Read more.

Magle Group announces acquisition of Saving Chlorine. Read more.

Devyser Diagnostics wins a procurement worth SEK 61,8 million in Italy. Read more.

Orion and Hamster A license agreement is signed for APORON for Parkinson's disease. Read more.

The control balance sheet shows that the equity in SUFFER less than half of the registered share capital and the board will call a first control meeting. Read more.

OncoZenge provides update on regulatory status of incoming investment. Read more.

RaySearch Laboratories announces that Odense University Hospital has placed an order for the dose planning system RayStation. Read more.

Egetis Therapeutics draws attention to the fact that a research article has been published in the journal Nature Communication. Read more.

Subscription period in Magnasenses A rights issue of units has been initiated. Read moreThe company publishes information about the rights issue. Read more.

NextCell Pharma presents details from the administrative subgroup analysis of ProTrans-Young. Read more.

DanCann Pharma publishes updated financial calendar. Read more.